Gene | Gene Full Name | DSI g | DPI g | pLI | Disease | Type | Score gda | EL gda | EI gda | N. PMIDs | N. SNPs gda | First Ref. | Last Ref. | ||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
tumor protein p53 | 0.236 | 0.962 | 0.53 |
|
phenotype | 0.600 | None | 0.936 | 578 | 13 | 1991 | 2020 | ||||||||
|
erb-b2 receptor tyrosine kinase 2 | 0.328 | 0.923 | 6.0E-03 |
|
phenotype | 0.600 | None | 0.970 | 560 | 7 | 1989 | 2020 | ||||||||
|
matrix metallopeptidase 9 | 0.305 | 0.923 | 1.9E-17 |
|
phenotype | 0.600 | None | 0.991 | 450 | 4 | 1996 | 2020 | ||||||||
|
matrix metallopeptidase 2 | 0.333 | 0.923 | 0.84 |
|
phenotype | 0.600 | None | 0.983 | 297 | 2 | 1993 | 2020 | ||||||||
|
prostaglandin-endoperoxide synthase 2 | 0.314 | 0.962 | 1.00 |
|
phenotype | 0.600 | None | 0.968 | 154 | 0 | 1998 | 2020 | ||||||||
|
CD82 molecule | 0.507 | 0.731 | 1.3E-08 |
|
phenotype | 0.600 | None | 0.973 | 150 | 0 | 1995 | 2019 | ||||||||
|
annexin A1 | 0.442 | 0.885 | 1.2E-07 |
|
phenotype | 0.600 | None | 0.958 | 24 | 0 | 1998 | 2019 | ||||||||
|
dihydrofolate reductase | 0.513 | 0.808 | 3.4E-02 |
|
phenotype | 0.550 | None | 1.000 | 6 | 1 | 1994 | 2019 | ||||||||
|
epidermal growth factor receptor | 0.295 | 0.885 | 0.37 |
|
phenotype | 0.400 | None | 0.973 | 520 | 10 | 1988 | 2020 | ||||||||
|
vascular endothelial growth factor A | 0.266 | 0.923 | 2.4E-05 |
|
phenotype | 0.400 | None | 0.976 | 503 | 4 | 1994 | 2020 | ||||||||
|
C-X-C motif chemokine receptor 4 | 0.362 | 0.923 | 1.8E-02 |
|
phenotype | 0.400 | None | 0.989 | 374 | 4 | 2000 | 2020 | ||||||||
|
CD44 molecule (Indian blood group) | 0.363 | 0.962 | 2.4E-07 |
|
phenotype | 0.400 | None | 0.979 | 327 | 2 | 1990 | 2020 | ||||||||
|
catenin beta 1 | 0.303 | 0.885 | 1.00 |
|
phenotype | 0.400 | None | 0.962 | 317 | 1 | 1996 | 2020 | ||||||||
|
phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha | 0.292 | 0.923 | 1.00 |
|
phenotype | 0.400 | None | 0.976 | 291 | 3 | 2003 | 2020 | ||||||||
|
NME/NM23 nucleoside diphosphate kinase 1 | 0.443 | 0.808 | 3.2E-03 |
|
phenotype | 0.400 | None | 0.940 | 285 | 1 | 1989 | 2020 | ||||||||
|
signal transducer and activator of transcription 3 | 0.320 | 0.923 | 1.00 |
|
phenotype | 0.400 | None | 0.996 | 249 | 0 | 2001 | 2020 | ||||||||
|
estrogen receptor 1 | 0.324 | 0.962 | 1.00 |
|
phenotype | 0.400 | None | 0.962 | 234 | 3 | 1992 | 2020 | ||||||||
|
C-X-C motif chemokine ligand 12 | 0.379 | 0.846 | 0.12 |
|
phenotype | 0.400 | None | 0.995 | 219 | 1 | 2000 | 2020 | ||||||||
|
KRAS proto-oncogene, GTPase | 0.320 | 0.923 | 7.9E-04 |
|
phenotype | 0.400 | None | 0.952 | 207 | 7 | 1991 | 2020 | ||||||||
|
secreted phosphoprotein 1 | 0.353 | 0.885 | 2.1E-06 |
|
phenotype | 0.400 | None | 0.989 | 190 | 0 | 1996 | 2020 | ||||||||
|
transforming growth factor beta 1 | 0.287 | 0.962 | 3.7E-02 |
|
phenotype | 0.400 | None | 0.982 | 168 | 2 | 1994 | 2020 | ||||||||
|
phosphatase and tensin homolog | 0.305 | 0.923 | 0.26 |
|
phenotype | 0.400 | None | 0.976 | 165 | 1 | 1997 | 2020 | ||||||||
|
S100 calcium binding protein A4 | 0.448 | 0.769 | 6.2E-03 |
|
phenotype | 0.400 | None | 0.962 | 160 | 0 | 1992 | 2020 | ||||||||
|
twist family bHLH transcription factor 1 | 0.397 | 0.846 | 0.34 |
|
phenotype | 0.400 | None | 0.980 | 149 | 0 | 2004 | 2019 | ||||||||
|
heparanase | 0.425 | 0.808 | 2.3E-14 |
|
phenotype | 0.400 | None | 0.972 | 144 | 0 | 1999 | 2020 |